TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Good response on IIQ
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: handover performance ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: handover clinical judgement ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: handover self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean percentage of persisting BoP-positive sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean PISA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean GI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Expressive language improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: IADL score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handgrip strength change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static respiratory system compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severe late-onset OHSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apnoea‐Hypopnoea Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time to stone expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain episodes requiring analgesia
Endpoint domain: Adverse events/effects
Primary endpoint: Participation rate in intervention components
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Bonus compensation triggered for affected patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality circle attendance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: postoperative maximum NT-proBNP concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of MINS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Active range of motions in anterior/posterior translation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flexion at the end of the terminal stance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior translation of the tibia during gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of active EBV infection markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of pneumonia in patients with active EBV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Exceeding reference values of ALT and relative number of monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during STUT insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience of the STUT procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvements in clinicians' EBP beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvements in clinicians' EBP practices
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: improvements in patient safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum levels of liver enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission rate (achieving grade 0 hepatic steatosis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: mean change in weekly attack frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: injection site-related treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of negative dysphotopsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged opioid use after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in overall oral health status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plaque level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Issuance of DNR orders before death
Endpoint domain: Mortality/survival
Primary endpoint: Endotracheal intubation and mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of re-hospitalisation or colectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Day 3 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical rating pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores achieved by students
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Thrombotic Events (TEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Nonmajor CRB events
Endpoint domain: Adverse events/effects
Primary endpoint: Prevention of AF recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical pregnancy rate
Endpoint domain: Physiological/clinical
Primary endpoint: Time required for automated segmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dice similarity coefficient (DSC) for identification accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-observer consistency (DSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: continuous margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in caregiver's knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in disease preparedness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in advance care planning completion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean volume of fluid administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24-h integrated gastric acidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety and tolerability of polyethylene glycolated exenatide injection
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum observed plasma concentration of metoprolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve for metoprolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall VSS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of post-TA atrophy
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of hypopigmentation
Endpoint domain: Adverse events/effects
Primary endpoint: parent-reported daily life EF
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: MCA LF gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: DFA (Dynamic Functional Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area under the plasma drug concentration versus time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-conversion to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived relevance of community dialogue for addressing SRH issues
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: weekly intake of vegetables on sandwiches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WW session attendance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Engagement with WW digital tools
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Engagement with WW mobile app
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Onset and progression of diabetic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SctO2%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number of falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in OLP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visceral Sensitivity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Catastrophizing Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief of 50% or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incomplete defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: blockage sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: liquid stools without the aid of laxatives
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Endometrial receptivity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of participants with confirmed hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Spatial and verbal memory scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: time of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: FMA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Annual all-cause total costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Annual ovarian cancer-related total costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of RAS
Endpoint domain: Adverse events/effects
Primary endpoint: fluid overload measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global cognitive functions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Lowest mean SpO2 during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Visceral fat volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of radiotherapy-induced temporal lobe injury (RTLI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Health costs savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Appendicular BMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Appendicular BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Distress and Impact Thermometer scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Likelihood of resignations
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Cardiovascular regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CVA/stroke rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: 3-year variceal rebleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vascular conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Perceived ambiguity regarding MCI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: availability of fruits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: availability of vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of grade B/C postoperative liver failure
Endpoint domain: Mortality/survival
Primary endpoint: Prediction of SGA neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Puerperal infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of IPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Provision of skin-to-skin contact (STSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provision of breastmilk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean serum urate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of gout flares requiring treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in RALE over time
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of infants with vitamin D sufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum 25(OH) D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coding
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Picture Completion
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: composite primary efficacy outcome of cardiovascular death, stroke, or hospitalization for worsening of heart failure or for acute coronary syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: primary safety outcome (death, stroke, or serious adverse events of rhythm control therapy)
Endpoint domain: Adverse events/effects
Primary endpoint: herpes infections
Endpoint domain: Adverse events/effects
Primary endpoint: total vascular resistance (TVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: de novo hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ejaculatory preservation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: change in MSHQ Ejaculation Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Satisfaction with the process of managing abnormal cancer screening test results
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of MCI diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean second phase of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater [11C]‐raclopride binding potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lower resting-state striatal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stronger increase in functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reduction in PC versus standard care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VRE infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: C. difficile infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of incision infection
Endpoint domain: Adverse events/effects
Primary endpoint: Knee joint VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Further bleeding within 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: step counts per 24-h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for nonopioid analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients discharged with a VAS score <30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of analgesic users
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of opioid users
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Probability of confirmed disability worsening (CDW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heel-rise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of symptomatic, antibiotic-treated urinary tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: postoperative hospital-stay length
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Objective colour change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OHRQoL (Oral Health-Related Quality of Life)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Restoration of normothermia (≥ 36.5 °C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut microbiota modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cumulative opioid dose in fentanyl equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total cumulative infused PCA volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean overall score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in positive affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in non-phobic anxiety disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prenatal distress and pregnancy-related anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: pleurodesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: late dysuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: late urinary retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: average deviation in maxilla repositioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of CD40 RO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antispastic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 5-year survival rates for unresected or late cases
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients achieving DAPSA‐REM or VLDA status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient global assessment ≤10 mm and ≤20 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician global assessment ≤10 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of thermocoagulation
Endpoint domain: Physiological/clinical
Primary endpoint: Efficacy of cryotherapy
Endpoint domain: Physiological/clinical
Primary endpoint: Incidence of AKI based on RIFLE criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mobility of trunk flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactivation of CMV
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of severe acute GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of pp65-specific T cells with effector memory phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: trailing limb angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: paretic pushoff
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in internalized stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rates of CNLDO procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ITN ownership
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health behavior with respect to metabolic syndrome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ht SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF‐1 SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes